International Patent: AN ENDOGENOUS PEPTIDE, PEPTIDOMIMETIC AND ITS SMALL MOLECULE MIMETIC AS NOVEL ANTICANCER AGENTS

GENEVA, Aug. 7 -- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA filed a patent application (US2025/057132) for “AN ENDOGENOUS PEPTIDE, PEPTIDOMIMETIC AND ITS SMALL MOLECULE MIMETIC AS NOVEL ANTICANCER AGENTS”. With publication no. WO/2026/164725, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/17

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....